Primary Ovarian Insufficiency Clinical Trial
Official title:
Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Stem Cell (MSC)-Like Cells Transplantation in Women With Primary Ovarian Insufficiency (POI)
There is a high incidence of women suffering from Primary Ovarian Insufficiency (POI). So far, there was no treatment sufficient enough to cure POI. Cell therapy is a rapidly developing field and have shown immense promise in the treatment of ovarian dysfunction. In this study, the investigator will evaluate the safety of MSC-like cell therapy in women suffering from POI.
The purpose of this work is to explore the safety and preliminary efficacy of human embryonic stem cell derived MSC-like cell transplantation in women with POI. MSC-like cells were injected directly into bilateral ovaries under transvaginal ultrasound. Patients are subjected into 3 groups, with low (0.2×107), medium (0.5×107) and high dosage (1.0×107) of cells injection for each ovary. The outcomes of patients were followed after the injection every 2 weeks. The investigator mainly follow the safety indexes, and the level of sex hormone and signs of follicle growth will also be monitored. The growing follicles will be stimulated by exogenous hormone, followed by oocyte retrieval and in vitro fertilization (IVF). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02871986 -
Pubertal Induction in Individuals With Hypogonadism
|
N/A | |
Recruiting |
NCT02322060 -
In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency
|
||
Recruiting |
NCT06167135 -
Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
|
||
Active, not recruiting |
NCT04675970 -
Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
|
||
Completed |
NCT04943354 -
Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure
|
N/A | |
Recruiting |
NCT03518918 -
Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women
|
||
Recruiting |
NCT05021094 -
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
|
Phase 4 | |
Active, not recruiting |
NCT02795000 -
Development a Predictive Nomogram for Primary Ovarian Insufficiency
|
||
Suspended |
NCT03021915 -
Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure
|
N/A | |
Completed |
NCT01436513 -
A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.
|
Phase 1 | |
Recruiting |
NCT06117982 -
The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency
|
Phase 2 | |
Recruiting |
NCT02068976 -
Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)
|
||
Completed |
NCT01973075 -
Genetic Etiology in Premature Ovarian Insufficiency
|
N/A | |
Completed |
NCT03568708 -
Primary Ovarian Insufficiency: Phenotype and Optimal Treatment
|
Phase 3 | |
Not yet recruiting |
NCT02757469 -
Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
|
N/A | |
Completed |
NCT02091128 -
Pregnancy Chances in Classic Galactosemia
|
N/A | |
Terminated |
NCT00650754 -
Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility
|
Phase 2/Phase 3 | |
Recruiting |
NCT03496636 -
Autologous Ovarian Tissue Transplantation
|
N/A | |
Active, not recruiting |
NCT05737329 -
Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02922348 -
Hormone Replacement for Premature Ovarian Insufficiency
|
Phase 3 |